Literature DB >> 405103

Analytical characterization of lipopolysaccharide antigens from seven strains of Pseudomonas aeruginosa.

D Horton, G Rodemeyer, T H Haskell.   

Abstract

Lipopolysaccharide antigens from seven different serotype strains (antigen immunotypes Nos. 1-7 in the classification of Fisher et al.3) of Pseudomonas aeruginosa have been analyzed for neutral carbohydrate, amino sugars, lipid, protein, 3-deoxy-manno-octulosonic acid, and phosphorus. The individual amino sugars were determined for each antigen type; all contained 2-amino-2-deoxy-D-glucose and -D-galactose, together with 2-amino-2,6-dideoxygalactose; the latter as isolated from the type 2 antigen was identified as the DL form. In addition, 2-amino-2,6-dideoxy-D-glucose was present in the types 3, 4, and 5 antigens. Mild, acid hydrolysis of the antigens gave the lipid A component containing all of the lipid and 2-amino-2-deoxy-D-glucose, together with lipid A-free polysaccharides that contained principally carbohydrate. The lipid A-free polysaccharides all contained L-rhamnose and D-glucose, together with 2-amino-2,6-dideoxygalactose in all except those from types 1, 5, and 7; that from type 6 also contained D-xylose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405103     DOI: 10.1016/s0008-6215(00)84441-9

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  13 in total

1.  Cross-reactions of lipopolysaccharides of Pseudomonas aeruginosa in antipneumococcal and other antisera.

Authors:  M Heidelberger; D Horton; T H Haskell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  31P N.m.r. evidence for the presence of triphosphate residues in lipopolysaccharides from Pseudomonas aeruginosa.

Authors:  S G Wilkinson
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

3.  The absence of triphosphate or metaphosphate residues from lipopolysaccharides of the seven Fisher immunotypes of Pseudomonas aeruginosa.

Authors:  D Horton; D A Riley
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

4.  Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.

Authors:  S J Cryz; E Fürer; A S Cross; A Wegmann; R Germanier; J C Sadoff
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

5.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.

Authors:  S J Cryz; T L Pitt; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.

Authors:  R Gonggrijp; W J Mullers; C P van Boven
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; M Cohen; H Jennings
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

8.  2,3-diamino-2,3-dideoxy-D-glucofuranurono-6,3-lactam from the hydrolysate of Pseudomonas aeruginosa P14 lipopolysaccharide.

Authors:  S Okuda; N Suzuki
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

9.  High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

10.  Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.

Authors:  R Gonggrijp; W J Mullers; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.